LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹19 Cr | ₹-5.72 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-5.72 Cr |
| Mar2023 | ₹-8.32 Cr |
| Mar2022 | ₹-8.14 Cr |
| Mar2021 | ₹4.52 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-5.72 Cr | Negative | |
| Mar2023 | ₹-8.32 Cr | Negative | |
| Mar2022 | ₹-8.14 Cr | Negative | |
| Mar2021 | ₹4.52 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹127.4 Cr | -11.7% | 0.2% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -11.7% |
0.2% |
7.1% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses